Merck KGaA (MRCG.DE)
MRCG.DE on Xetra
118.25EUR
5:06am EDT
118.25EUR
5:06am EDT
Price Change (% chg)
€0.45 (+0.38%)
€0.45 (+0.38%)
Prev Close
€119.85
€119.85
Open
€118.00
€118.00
Day's High
€118.30
€118.30
Day's Low
€117.15
€117.15
Volume
46,589
46,589
Avg. Vol
259,555
259,555
52-wk High
€127.50
€127.50
52-wk Low
€76.95
€76.95
About
Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of... (more)
Overall
| Beta: | 0.46 |
| Market Cap (Mil.): | €7,612.37 |
| Shares Outstanding (Mil.): | 64.62 |
| Dividend: | 1.70 |
| Yield (%): | 1.44 |
Financials
| MRCG.DE | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 38.80 | 32.92 | 33.02 |
| EPS (TTM): | 3.04 | -- | -- |
| ROI: | 3.85 | 19.76 | 19.07 |
| ROE: | 6.27 | 20.57 | 20.00 |
Swiss billionaires buy Merck Serono HQ for biotech campus
* Merck to sell Geneva site to Bertarelli-backed consortium
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Finlabo SIM Spa
|
$10.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

